GNRSU The Greenrose Holding Co. (PNK) down 99.99% on 08 Jan 2026: liquidity risk flagged
The GNRSU stock collapsed intraday, trading at USD 1e-06 after a sharp fall from a $0.15 close, marking a near 99.99% decline on 08 Jan 2026 during market hours. This move pushed market cap to about $13.00 and volume to 145.00 shares, highlighting extreme illiquidity on the PNK exchange in the United States. Investors should note the divergence between the company’s trailing EPS of 3.10 and the micro share price. We review fundamentals, trading metrics, Meyka AI grading, and forecast scenarios to frame the top losers context for GNRSU stock.
GNRSU stock market move snapshot
GNRSU The Greenrose Holding Company Inc. (PNK) opened at USD 0.000001 and is quoted at USD 1e-06 after a one-day change of -99.99%. The immediate driver is a collapse in traded price versus the 50-day average $0.15, indicating either a delisting risk, consolidation of free float, or a corporate action. Trade volume remained light at 145.00, which magnifies price swings and raises execution risk for holders.
GNRSU stock fundamentals and valuation
On paper Greenrose shows trailing metrics that look odd against the micro price. The company reports EPS 3.10 and a price-to-earnings outcome that is effectively zero at the current price level. Book value per share is 4.30, cash per share 0.56, and shares outstanding 12,853,627.00, implying balance-sheet value disconnected from market price. Current ratio and days-of-inventory figures point to working capital stress, with a current ratio 0.21 and inventory days 439.24.
Trading profile, liquidity and technicals for GNRSU stock
Liquidity is the central technical risk—average volume data is missing and daily volume of 145.00 is negligible. The quoted year high is $0.15 and year low USD 1e-06, showing full-range collapse. With low float activity, bid-ask spreads can be wide and slippage large. For active traders, strict order limits and limit-only executions are advisable to control entry and exit costs.
Meyka AI grade, forecast and model view on GNRSU stock
Meyka AI rates GNRSU with a score out of 100: 67.23 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, industry metrics, financial growth, key ratios, forecasts, and analyst signals. Meyka AI’s forecast model projects $0.00 as a one-year model output versus current price USD 1e-06, implying an effective downside to the quoted micro price. Forecasts are model-based projections and not guarantees.
Risks, catalysts and sector context
Greenrose operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, and in cannabis production. The sector faces regulatory, supply-chain, and reimbursement risks that can amplify moves for micro-cap names. Short-term catalysts would include audited filings, reverse splits, or exchange status updates. Key risks remain delisting, low liquidity, and working capital pressure reflected in negative net current asset values.
Price targets, scenarios and investment implications for GNRSU stock
Given extreme price displacement, scenario planning is essential. A conservative recovery scenario: $0.01 (implied +999900.00% vs USD 1e-06) if liquidity and listing actions restore trade. Base scenario: $0.05 if operations and disclosures improve. Bull case: $0.10 with successful strategic moves. These scenario targets are illustrative, not guarantees, and depend on corporate actions and sector trends.
Final Thoughts
Key takeaways for GNRSU stock: the share price at USD 1e-06 versus a previous close of $0.15 shows a near 99.99% intraday collapse driven by ultra-low liquidity and price reporting quirks. Balance-sheet metrics such as book value per share $4.30 and EPS 3.10 conflict with the market quote, creating valuation noise. Meyka AI rates GNRSU 67.23/100 (Grade B, Suggestion: HOLD) and flags liquidity and corporate-action risk as primary concerns. Meyka AI’s forecast model projects $0.00 one-year output against the current USD 1e-06 price; this reflects model sensitivity to quoted micro prices and missing market activity. Scenario-based price targets—$0.01, $0.05, $0.10—show the wide range of potential outcomes and the high volatility in recovery paths. Investors should treat GNRSU as speculative, confirm exchange status and filings, and size positions for potential total loss. This piece uses Meyka AI as an AI-powered market analysis platform to present data-driven context, not investment advice. For company filings and updates consult official disclosures and trading platforms before acting.
FAQs
Why did GNRSU stock fall so sharply today?
The sharp fall reflects extreme illiquidity on PNK, a price quote near USD 1e-06, and likely corporate or market reporting actions. Low volume (145.00) magnifies price moves more than fundamental changes.
Is GNRSU stock undervalued given its EPS and book value?
On a balance-sheet basis GNRSU shows book value $4.30 and EPS 3.10, but micro pricing, trading suspension risk, and negative working capital remove straightforward valuation comparisons.
What should holders of GNRSU stock do now?
Holders should verify exchange status, review company filings, and consider the high liquidity and delisting risks. Position sizing and limit orders are prudent given the micro-cap trading dynamics.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
